AJMC September 13, 2024
Laura Joszt, MA

Panelists discussed how the Inflation Reduction Act and the Enhancing Oncology Model are impacting value in cancer care and access to treatment.

With the Inflation Reduction Act (IRA) now being implemented and the Enhancing Oncology Model (EOM) enacting changes and opening up for a second round of applications to join, a panel of experts at the Patient-Centered Oncology Care® meeting discussed what is improving access, impacting innovation, and creating value in cancer care.

Ryan Haumschild, PharmD, MS, MBA, CPEL, vice president of pharmacy, Emory Healthcare and Winship Cancer Institute, moderated the discussion and was joined by:

  • Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, clinical pharmacy manager, Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center
  • Bruce Wilson,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Conferences / Podcast, Provider, Trends
Related Articles:
Funding announced to boost development of health tech for cancer
Hurricane Milton disrupts infrastructure, could trigger more hospital evacuations in Florida
Why Physicians and PAs Should Come Together for Patients
Study shows Lunit AI can predict breast cancer years before it is clinically detectable
The best states for women's health

Share This Article